Abstract
Summary
The global respiratory care devices market is projected to reach USD 31.8 billion by 2028 from USD 21.8 billion in 2023, at a CAGR of 7.8%. Rising prevalence of respiratory diseases as a result of the rapid growth in the global geriatric population will drive the market growth.
COPD and asthma are the most prevalent respiratory disorders across the globe. As per the WHO, COPD is the third leading cause of death worldwide, causing 3.2 million deaths in 2019. More than 80% of these deaths have occurred in low and middle-income countries. Over 380 million people globally are anticipated to have COPD. Largely undiagnosed COPD patients are high in regions and countries, such as China, India, Brazil, and Eastern Europe. The cost incurred to healthcare systems for COPD across the globe is nearly USD 50 billion annually. Some of the major causes of COPD are long-term asthma and prolonged exposure to tobacco smoke, indoor & outdoor air pollution, and occupational fumes & dust. Other comorbid chronic conditions, including cardiovascular disease, musculoskeletal impairment, and diabetes mellitus, are related to COPD. These conditions may also impact the health status of patients, as well as interfere with COPD management.
“The ventilators segment holds the major share of the therapeutic respiratory care devices market”
The therapeutic respiratory care devices market is segmented into ventilators, positive airway pressure (PAP) devices, humidifiers, nebulizers, oxygen concentrators, reusable resuscitators, inhalers, masks, nitric oxide delivery units, and oxygen hoods. In 2022, the ventilators segment holds the major share of the therapeutic respiratory care devices market. A large share of the ventilator segment can be attributed to the rising number of intensive care beds equipped with ventilators, increasing ICU admission and re-admissions in developed countries, and the favorable reimbursement scenario.
“The COPD segment holds the major share of the respiratory care devices market”
By disease indiation the respiratory care devices market is segmented into chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, infectious diseases, and other disease indications. The COPD segment holds the major share of the respiratory care devices market. A large share of the COPD segment can be attributed to the tobacco smoking, genetic disorders, and the increasing geriatric population. The high prevalence of COPD and the growing number of deaths caused by COPD are expected to drive the demand for respiratory care devices during the forecast period.
“The hospitals segment holds the major share of the respiratory care devices market”
By end user the respiratory care devices market is segmented into hospitals, home care settings, ambulatory care centers (ACCs), and other end users. The hospitals segment holds the major share of the respiratory care devices market. A large share of the hospitals segment can be attributed to the financial capabilities of hospitals to purchase expensive equipment and the availability of trained professionals in hospitals to operate respiratory care devices. Additionally, the trend of economic expansion and government focus on broader welfare policies has led to the growth of the healthcare sector in emerging economies.
“Asia Pacific will grow at highest CAGR during the forecast period”
In 2022, Asia Pacific will grow at highest CAGR during the forecast period. The high growth in this market can majorly be attributed to the to high-growth markets such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore. In these countries, the rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players.
“Improved profitability & mobility and enhanced remote moitoring–unmet needs in the respiratory care devices market”
• Many respiratory patients need oxygen therapy but require more lightweight, compact devices for increased mobility. Currently available portable devices may not fully meet this need.
• There's a growing demand for remote patient monitoring to reduce hospital admissions and improve patient outcomes. However, existing solutions may lack full integration or real-time data transmission.
The break-up of the profile of primary participants in the the respiratory care devices market (Supply Side):
• By Company Type: Tier 1 – 35%, Tier 2 – 40%, and Tier 3 – 25%
• By Designation: C Level – 20%, Director Level – 35%, Others-45%
• By Region: North America – 30%, Europe – 27%, Asia Pacific – 25%, Middle East – 10%, and Latin America – 8%
The break-up of the profile of primary participants in the the respiratory care devices market (Demand Side):
• By End User: Hospitals- 47%, Home Care- 33%, Others-20%
• By Designation: Doctors-35%, Diagnostic Centre Lab Heads-27%, Hospital Directors & Managers-22%, Others-16%
• By Region: North America-34%, Europe-22%, Asia Pacific-20%, Latin America-16%, Middle East & Africa-8%
The prominent players in the the respiratory care devices market include Koninklijke Philips N.V. (Netherlands), General Electric Healthcare (US), ResMed Inc. (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Medtronic plc (Ireland), Masimo Corporation (US), Drägerwerk AG & Co.(Germany), Getinge AB (Sweden), Nihon Kohden Corporation (US), Vyaire Medical (US), Hill-Rom, Inc. (US), AdaptHealth LLC (US), Rotech Healthcare, Inc. (US), Teleflex Incorporated(Japan), Air Liquide (France), Invacare Corporation (US), ICU Medical Inc. (US), Hamilton Medical AG (Switzerland), Apex Medical Corporation (Taiwan), Apex Medical Corporation (US), HUM GmbH (Germany), Nonin Medical (US), Allied Healthcare Products, Inc. (US), Drive DeVilbiss Healthcare (US), OMRON Healthcare, Inc. (Japan).
Research Coverage:
The report analyzes the respiratory care devices market and aims at estimating the market size and future growth potential of this market based on various segments such as product, disease indication, end user and region. The report also includes a product portfolio matrix of various respiratory care devices available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall respiratory care devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
• Analysis of key drivers (Rising Prevalence of Respiratory Diseases, Increasing incidence rate of preterm births, Outbreak of infectious diseases affecting the respiratory system, Underpenetrated markets in sleep and COPD, Focus on improving patient outcomes, Rising R&D investments resulting in technologically advanced devices), restraints (Unfavorable reimbursement scenario, Availability of low-cost products from local manufacturers, High cost of CPAP machines), opportunities (Growing demand for home care therapeutic devices, High growth in developing countries, Point-of-care Diagnostics, Growing awareness about the ill-effects of untreated sleep apnea), and challenges (Low awareness and a large underdiagnosed and undertreated population, Harmful effects of certain devices on neonates)
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the respiratory care devices market
• Market Development: Comprehensive information on the lucrative emerging markets by product, disease indication, end user and region.
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global respiratory care devices market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players like Koninklijke Philips N.V. (Netherlands), General Electric Healthcare (US), ResMed Inc. (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), and Medtronic plc (Ireland) in the global respiratory care devices market.
Table of Contents
1 INTRODUCTION 55
1.1 STUDY OBJECTIVES 55
1.2 MARKET DEFINITION 55
1.2.1 INCLUSIONS AND EXCLUSIONS 55
1.3 MARKET SCOPE 56
1.3.1 MARKETS COVERED 56
1.3.2 YEARS CONSIDERED 57
1.4 CURRENCY CONSIDERED 58
1.5 STAKEHOLDERS 58
1.6 LIMITATIONS 58
1.7 SUMMARY OF CHANGES 58
1.8 RECESSION IMPACT 59
2 RESEARCH METHODOLOGY 60
2.1 RESEARCH DATA 60
2.1.1 SECONDARY DATA 61
- 2.1.1.1 Key data from secondary sources 62
2.1.2 PRIMARY DATA 62
- 2.1.2.1 Key data from primary sources 64
- 2.1.2.2 Key industry insights 64
2.2 MARKET SIZE ESTIMATION 66
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 73
2.4 STUDY ASSUMPTIONS 74
2.4.1 MARKET SHARE ASSUMPTIONS 74
2.4.2 RESEARCH ASSUMPTIONS 74
2.5 RISK ASSESSMENT 74
2.6 RESEARCH LIMITATIONS 74
2.7 RECESSION IMPACT ANALYSIS 75
3 EXECUTIVE SUMMARY 76
4 PREMIUM INSIGHTS 80
4.1 RESPIRATORY CARE DEVICES MARKET OVERVIEW 80
4.2 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY TYPE (2022) 81
4.3 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 82
4.4 RESPIRATORY CARE DEVICES MARKET: REGIONAL MIX 82
4.5 RESPIRATORY CARE DEVICES MARKET: DEVELOPED VS. EMERGING ECONOMIES 83
5 MARKET OVERVIEW 84
5.1 INTRODUCTION 84
5.2 MARKET DYNAMICS 84
5.2.1 DRIVERS 85
- 5.2.1.1 Rising prevalence of respiratory diseases 85
- 5.2.1.1.1 Rapid growth in global geriatric population 86
- 5.2.1.1.2 Urbanization and growing pollution levels 86
- 5.2.1.1.3 Growing tobacco consumption 87
- 5.2.1.1.4 Increased adoption of sedentary lifestyles 88
- 5.2.1.2 Surging incidence rate of preterm births 88
- 5.2.1.3 Growing outbreaks of infectious diseases affecting respiratory systems 89
- 5.2.1.4 Rising population with sleep disorders 89
- 5.2.1.5 Improved patient outcomes using respiratory care devices 90
- 5.2.1.6 Surging R&D investments for technological advancement of medical devices 90
- 5.2.1.1 Rising prevalence of respiratory diseases 85
5.2.2 RESTRAINTS 91
- 5.2.2.1 Unfavorable reimbursement scenario for respiratory care diagnostics 91
- 5.2.2.2 Availability of low-cost products from local manufacturers 91
- 5.2.2.3 High cost of CPAP machines 92
5.2.3 OPPORTUNITIES 92
- 5.2.3.1 Growing demand for home care therapeutic devices 92
- 5.2.3.2 Market growth opportunities in Asia Pacific and Latin America 93
- 5.2.3.3 Increasing preference for self-testing 93
- 5.2.3.4 Growing awareness about ill effects of untreated sleep apnea 94
5.2.4 CHALLENGES 95
- 5.2.4.1 Low awareness and lack of diagnosis of respiratory diseases 95
- 5.2.4.2 Harmful effects of certain respiratory care devices on neonates 95
- 5.2.4.3 Lack of patient compliance with CPAP therapy 96
5.3 INDUSTRY TRENDS 96
5.3.1 RISING DEMAND FOR ENHANCED COMPACT AND PORTABLE DEVICES 96
5.3.2 KEY FOCUS OF MARKET PLAYERS ON GEOGRAPHICAL EXPANSION 96
5.3.3 GROWING DEMAND FOR MULTIMODAL VENTILATION 97
5.3.4 RISING ADOPTION OF NON-INVASIVE VENTILATION 97
5.4 REGULATORY ANALYSIS 98
5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
5.4.2 NORTH AMERICA 99
- 5.4.2.1 US 99
- 5.4.2.2 Canada 100
5.4.3 EUROPE 100
5.4.4 ASIA PACIFIC 101
- 5.4.4.1 Japan 101
- 5.4.4.2 China 102
- 5.4.4.3 India 103
5.5 ECOSYSTEM ANALYSIS 103
5.6 VALUE CHAIN ANALYSIS 104
5.7 IMPACT OF COVID-19 ON RESPIRATORY CARE DEVICES MARKET 105
5.8 TECHNOLOGY ANALYSIS 106
5.8.1 E-NOSE TECHNOLOGY 106
5.8.2 MEMS TECHNOLOGY 106
5.8.3 ELECTROCHEMICAL TECHNOLOGY 106
5.8.4 WIRELESS GAS SENSOR TECHNOLOGY 107
5.9 PATENT ANALYSIS 107
5.9.1 PATENT PUBLICATION TRENDS FOR RESPIRATORY CARE DEVICES 107
5.9.2 TOP APPLICANTS FOR RESPIRATORY CARE DEVICE PATENTS, BY GEOGRAPHY (2015-2023) 108
5.9.3 RESPIRATORY CARE DEVICES MARKET: TOP APPLICANTS 108
5.10 TRADE ANALYSIS 109
5.11 CASE STUDY ANALYSIS 110
5.12 PORTER’S FIVE FORCES ANALYSIS 111
5.12.1 THREAT OF NEW ENTRANTS 111
5.12.2 THREAT OF SUBSTITUTES 112
5.12.3 BARGAINING POWER OF SUPPLIERS 112
5.12.4 BARGAINING POWER OF BUYERS 112
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 112
5.13 KEY CONFERENCES AND EVENTS, 2023-2024 113
5.13.1 RESPIRATORY CARE DEVICES MARKET: LIST OF KEY CONFERENCES AND EVENTS 113
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 113
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 113
5.14.2 BUYING CRITERIA 115
5.15 PRICING ANALYSIS 116
5.16 UNMET NEEDS PERTAINING TO RESPIRATORY CARE DEVICES 116
5.16.1 END USER EXPECTATIONS 117
5.17 APPLICATION OF ARTIFICIAL INTELLIGENCE IN RESPIRATORY CARE DEVICES 119
5.17.1 FUTURE OF HEALTHCARE-BIG DATA AND ARTIFICIAL INTELLIGENCE 119
5.18 REIMBURSEMENT SCENARIO 120
6 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT 122
6.1 INTRODUCTION 123
6.2 THERAPEUTIC RESPIRATORY CARE DEVICES 124
6.2.1 PAP DEVICES 126
- 6.2.1.1 CPAP devices 128
- 6.2.1.1.1 Growing popularity of nasal CPAP therapies to drive demand 128
- 6.2.1.2 APAP devices 130
- 6.2.1.2.1 Rising awareness among sleep specialists and patients regarding additional features of APAP devices to boost market 130
- 6.2.1.3 BiPAP devices 132
- 6.2.1.3.1 Increasing number of hospitals to strengthen market 132
- 6.2.1.1 CPAP devices 128
6.2.2 VENTILATORS 134
- 6.2.2.1 ICU ventilators 136
- 6.2.2.1.1 High-end ventilators 139
- 6.2.2.1.1.1 Improving healthcare infrastructure and rising healthcare expenditure to drive market 139
- 6.2.2.1.2 Mid-end ventilators 140
- 6.2.2.1.2.1 Better affordability and accessibility of mid-end ventilators than high-end models to support market growth 140
- 6.2.2.1.3 Basic ventilators 142
- 6.2.2.1.3.1 Expanding access to critical healthcare facilities in developing countries to spur demand 142
- 6.2.2.1.1 High-end ventilators 139
- 6.2.2.2 Portable/Transportable ventilators 143
- 6.2.2.2.1 Increasing demand for home care to boost segmental growth 143
- 6.2.2.1 ICU ventilators 136
6.2.3 NEBULIZERS 146
- 6.2.3.1 Jet nebulizers 149
- 6.2.3.1.1 Increasing prevalence of respiratory conditions to augment market size 149
- 6.2.3.2 Mesh nebulizers 151
- 6.2.3.2.1 Deployment of advanced aerosolization technology to drive market 151
- 6.2.3.3 Ultrasonic nebulizers 152
- 6.2.3.3.1 Adjustable settings for particle size and treatment duration to boost market 152
- 6.2.3.1 Jet nebulizers 149
6.2.4 HUMIDIFIERS 154
- 6.2.4.1 Heated humidifiers 156
- 6.2.4.1.1 Ease of control and customizability to grow market 156
- 6.2.4.2 Passover humidifiers 158
- 6.2.4.2.1 Minimal maintenance and simple technology to spur demand 158
- 6.2.4.1 Heated humidifiers 156
6.2.5 OXYGEN CONCENTRATORS 160
- 6.2.5.1 Fixed oxygen concentrators 162
- 6.2.5.1.1 Better access to healthcare services to grow demand 162
- 6.2.5.2 Portable oxygen concentrators 163
- 6.2.5.2.1 Low weight and easy setup to drive segmental growth 163
- 6.2.5.1 Fixed oxygen concentrators 162
6.2.6 INHALERS 165
- 6.2.6.1 Metered-dose inhalers (MDIs) 167
- 6.2.6.1.1 Ongoing advancements in MDI technology to support market growth 167
- 6.2.6.2 Dry powder inhalers (DPIs) 168
- 6.2.6.2.1 Developments in particle engineering and powder formulations to boost segmental growth 168
- 6.2.6.1 Metered-dose inhalers (MDIs) 167
6.2.7 REUSABLE RESUSCITATORS 170
- 6.2.7.1 Disposable and reusable nature to drive demand 170
6.2.8 NITRIC OXIDE DELIVERY UNITS 172
- 6.2.8.1 Rising emphasis of companies on developing innovative and advanced nitric oxide delivery units to drive market 172
6.2.9 OXYGEN HOODS 174
- 6.2.9.1 Growing prevalence of respiratory diseases in kids to drive market growth 174
6.3 MONITORING DEVICES 176
6.3.1 PULSE OXIMETERS 177
- 6.3.1.1 Pulse oximeter sensors 180
- 6.3.1.1.1 Development of advanced sensors with embedded chips to boost segmental growth 180
- 6.3.1.2 Pulse oximeter equipment 181
- 6.3.1.2.1 Growing prevalence of chronic respiratory conditions to boost demand 181
- 6.3.1.1 Pulse oximeter sensors 180
6.3.2 CAPNOGRAPHS 183
- 6.3.2.1 Ongoing R&D on capnographs to offer lucrative growth opportunities 183
6.3.3 GAS ANALYZERS 185
- 6.3.3.1 Increasing demand for point-of-care testing to drive demand 185
6.4 DIAGNOSTIC RESPIRATORY CARE DEVICES 187
6.4.1 SPIROMETERS 188
- 6.4.1.1 Rising technological advancements in spirometers to support market growth 188
6.4.2 POLYSOMNOGRAPHY DEVICES (PSG DEVICES) 191
- 6.4.2.1 Rising incidence of obstructive sleep apnea to drive demand 191
6.4.3 PEAK FLOW METERS 193
- 6.4.3.1 Low-cost and uncomplicated nature to drive segmental growth 193
6.4.4 OTHER DIAGNOSTIC DEVICES 195
6.5 CONSUMABLES & ACCESSORIES 196
6.5.1 MASKS 197
- 6.5.1.1 Reusable masks 199
- 6.5.1.1.1 Growing concerns related to air pollution to grow demand 199
- 6.5.1.2 Disposable masks 200
- 6.5.1.2.1 Stringent government mandates on wearing masks to spur demand 200
- 6.5.1.1 Reusable masks 199
6.5.2 DISPOSABLE RESUSCITATORS 201
- 6.5.2.1 Growing focus on reducing cross-contamination cases in patients to foster segmental growth 201
6.5.3 TRACHEOSTOMY TUBES 202
- 6.5.3.1 Introduction of new and advanced products with ergonomic designs to drive market growth 202
6.5.4 BREATHING CIRCUITS 203
- 6.5.4.1 Healthcare professionals’ efforts to improve infection control practices to grow demand 203
6.5.5 NASAL CANNULAE 204
- 6.5.5.1 Increasing focus on minimally invasive surgery techniques to fuel demand 204
6.5.6 OTHER CONSUMABLES & ACCESSORIES 205
7 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION 206
7.1 INTRODUCTION 207
7.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) 207
7.2.1 RISING INDOOR AND OUTDOOR AIR POLLUTION LEVELS TO DRIVE MARKET 207
7.3 SLEEP APNEA 209
7.3.1 GROWING INCIDENCE OF OBESITY AND CARDIOVASCULAR DISEASES TO FAVOR MARKET GROWTH 209
7.4 ASTHMA 211
7.4.1 INCREASING INCIDENCE OF COPD TO DRIVE MARKET 211
7.5 INFECTIOUS DISEASES 212
7.5.1 GROWING NUMBER OF TB PATIENTS TO BOOST MARKET GROWTH 212
7.6 OTHER DISEASE INDICATIONS 213
8 RESPIRATORY CARE DEVICES MARKET, BY END USER 215
8.1 INTRODUCTION 216
8.2 HOSPITALS 216
8.2.1 GROWING NUMBER OF HOSPITALS IN EMERGING ECONOMIES TO DRIVE MARKET 216
8.3 HOME CARE SETTINGS 218
8.3.1 INCREASING ACCEPTANCE OF HOME CARE DEVICES BY PATIENTS TO BOOST GROWTH 218
8.4 AMBULATORY CARE CENTERS (ACCS) 219
8.4.1 IMPROVED PATIENT EXPERIENCE IN AMBULATORY CARE CENTERS TO DRIVE MARKET 219
8.5 OTHER END USERS 221
9 RESPIRATORY CARE DEVICES MARKET, BY REGION 222
9.1 INTRODUCTION 223
9.2 NORTH AMERICA 225
9.2.1 NORTH AMERICA: RECESSION IMPACT 232
9.2.2 US 232
- 9.2.2.1 Rapid growth in geriatric population to boost market 232
9.2.3 CANADA 239
- 9.2.3.1 Large pool of undiagnosed patients to drive market 239
9.3 EUROPE 245
9.3.1 EUROPE: RECESSION IMPACT 252
9.3.2 GERMANY 252
- 9.3.2.1 Increasing public healthcare expenditure to foster market growth 252
9.3.3 FRANCE 258
- 9.3.3.1 High prevalence of COPD to surge demand 258
9.3.4 UK 264
- 9.3.4.1 Growing demand for minimally invasive surgeries to drive market 264
9.3.5 ITALY 271
- 9.3.5.1 Growing involvement of private sector in healthcare market to drive market 271
9.3.6 SPAIN 277
- 9.3.6.1 Need to improve healthcare infrastructure due to aging demographic to drive demand 277
9.3.7 REST OF EUROPE 283
9.4 ASIA PACIFIC 289
9.4.1 ASIA PACIFIC: RECESSION IMPACT 296
9.4.2 JAPAN 297
- 9.4.2.1 Availability of universal healthcare reimbursement policy to drive market 297
9.4.3 CHINA 303
- 9.4.3.1 Initiatives to modernize healthcare system and reimbursement facilities to support market growth 303
9.4.4 INDIA 309
- 9.4.4.1 Increasing focus of global players on domestic market to drive market 309
9.4.5 AUSTRALIA 315
- 9.4.5.1 High prevalence of chronic lung diseases to drive demand 315
9.4.6 SOUTH KOREA 321
- 9.4.6.1 Expanding geriatric population to fuel market 321
9.4.7 REST OF ASIA PACIFIC 327
9.5 LATIN AMERICA 333
9.5.1 LATIN AMERICA: RECESSION IMPACT 339
9.5.2 BRAZIL 339
- 9.5.2.1 Government initiatives to improve healthcare sector to drive market 339
9.5.3 MEXICO 345
- 9.5.3.1 Rising obesity rate to increase incidence of respiratory diseases 345
9.5.4 REST OF LATIN AMERICA 351
9.6 MIDDLE EAST & AFRICA 357
9.6.1 PRESENCE OF UNSATURATED MARKETS TO OFFER LUCRATIVE GROWTH OPPORTUNITIES TO PLAYERS 357
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 363
10 COMPETITIVE LANDSCAPE 364
10.1 INTRODUCTION 364
10.2 RIGHT TO WIN/KEY STRATEGIES 364
10.3 STRATEGIES ADOPTED BY KEY PLAYERS 365
10.4 REVENUE ANALYSIS FOR TOP FIVE MARKET PLAYERS 366
10.5 MARKET SHARE ANALYSIS 366
10.6 COMPANY EVALUATION MATRIX 369
10.6.1 STARS 369
10.6.2 EMERGING LEADERS 369
10.6.3 PERVASIVE PLAYERS 369
10.6.4 PARTICIPANTS 370
10.7 COMPANY EVALUATION MATRIX FOR SMES/START-UPS (2022) 371
10.7.1 PROGRESSIVE COMPANIES 371
10.7.2 DYNAMIC COMPANIES 371
10.7.3 STARTING BLOCKS 371
10.7.4 RESPONSIVE COMPANIES 371
10.8 COMPETITIVE BENCHMARKING 373
10.8.1 COMPANY FOOTPRINT 374
10.8.2 COMPETITIVE SCENARIOS AND TRENDS 378
10.8.3 PRODUCT LAUNCHES 379
10.8.4 DEALS 379
11 COMPANY PROFILES 381
11.1 KEY PLAYERS 381
11.1.1 KONINKLIJKE PHILIPS N.V 381
11.1.2 MEDTRONIC 386
11.1.3 RESMED 391
11.1.4 MASIMO 398
11.1.5 FISHER & PAYKEL HEALTHCARE LIMITED 404
11.1.6 DRÄGERWERK AG & CO. KGAA 409
11.1.7 GETINGE 412
11.1.8 NIHON KOHDEN CORPORATION 415
11.1.9 GE HEALTHCARE 418
11.1.10 VYAIRE MEDICAL, INC 420
11.1.11 BAXTER INTERNATIONAL, INC 424
11.1.12 ADAPTHEALTH, LLC 428
11.1.13 ROTECH HEALTHCARE, INC 430
11.1.14 TELEFLEX INCORPORATED 431
11.1.15 AIR LIQUIDE 434
11.2 OTHER PLAYERS 438
11.2.1 INVACARE CORPORATION 438
11.2.2 ICU MEDICAL 441
11.2.3 HAMILTON MEDICAL AG 444
11.2.4 APEX MEDICAL CORP 447
11.2.5 MEDLINE INDUSTRIES, LP 449
11.2.6 HUM SOCIETY FOR HOMECARE AND MEDICAL TECHNOLOGY MBH 452
11.2.7 NONIN 454
11.2.8 ALLIED MEDICAL LLC 455
11.2.9 DRIVE DEVILBISS HEALTHCARE 456
11.2.10 OMRON HEALTHCARE, INC 457
12 APPENDIX 458
12.1 DISCUSSION GUIDE 458
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 465
12.3 CUSTOMIZATION OPTIONS 467
12.4 RELATED REPORTS 467
12.5 AUTHOR DETAILS 468